Inhibiting YB-1 phosphorylation on S102 by dual targeting of RSK and AKT was shown to be an efficient approach to block DSB repair and induce radiosensitization in breast cancer cells, independent of TNBC status [6]. This evidence concerns the gene RPS6KA1 and breast cancer.